MAPT and Alzheimer disease: APOE4 is a major genetic risk factor for AD and is implicated in multiple neurodegenerative processes within the brain, such as amyloid/tau accumulation, neuroinflammation, impaired synaptic plasticity, vascular dysfunction, and metabolism [54].